Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
C-VAX plus BCG versus placebo plus BCG after surgery for stage IV melanoma
ISRCTN72807124Phase 3Completed
- Sponsor
- United States Department of Health and Human Services
- Start
- Apr 1999
- Modality
- Vaccines & Immunotherapeutics
01
Overview
Phase 3, randomised, double-blind trial in melanoma comparing C-VAX plus BCG with Placebo plus BCG (2 arms). Primary endpoint: Progression-free survival. Started Apr 1999; status: completed.
02
Drugs
bcg vaccine
03
Conditions
melanoma
Beyond the preview
Go deeper on ISRCTN72807124.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN72807124.